Abstract
Introduction: There is a substantial lack of home-based exercise programs in the highly vulnerable group of geriatric patients with cognitive impairment (CI) after discharge from ward rehabilitation. Beyond clinical effectiveness, the cost-effectiveness of intervention programs to enhance physical performance is not well investigated in this target group. Objective: The aim of the study was to determine the cost-effectiveness of a 12-week home-based exercise intervention following discharge from ward rehabilitation compared to unspecified flexibility training for geriatric patients with CI from a societal perspective. Methods: This cost-effectiveness study was conducted alongside a randomized placebo-controlled trial. A total of 118 geriatric patients with CI (Mini-Mental State Examination score: 17–26) were randomized either to the intervention group (IG, n = 63) or control group (CG, n = 55). Participants in the IG received a home-based individually tailored exercise program to increase physical performance, while participants in the CG received unspecific flexibility training (placebo control). Healthcare service use, physical performance (Short Physical Performance Battery, SPPB), and quality of life (EQ-5D-3L) were measured over 24 weeks. The net monetary benefit (NMB) approach was applied to calculate incremental cost-effectiveness of the exercise intervention compared to the CG with respect to improvement of (a) physical performance on the SPPB and (b) quality-adjusted life years (QALYs). Results: Physical performance was significantly improved in the IG compared to the CG (mean difference at 24 weeks: 1.3 points; 95% confidence interval [95% CI] = 0.5–2.2; p = 0.003), while health-related quality of life did not significantly differ between the groups at 24 weeks (mean difference: 0.08; 95% CI = −0.05 to 0.21; p = 0.218). Mean costs to implement the home-based exercise intervention were EUR 284 per patient. The probability of a positive incremental NMB of the intervention reached a maximum of 92% at a willingness to pay (WTP) of EUR 500 per point on the SPPB. The probability of cost-utility referring to QALYs was 85% at a WTP of EUR 5,000 per QALY. Conclusion: The home-based exercise intervention demonstrated high probability of cost-effectiveness in terms of improved physical performance in older adults with CI following discharge from ward rehabilitation, but not in terms of quality of life.
References
1.
Reinhardt
UE
. Does the aging of the population really drive the demand for health care?
Health Aff
. 2003
;22
(6
):27
–39
. .2.
Bickel
H
, Hendlmeier
I
, Heßler
JB
, Junge
MN
, Leonhardt-Achilles
S
, Weber
J
, et al The prevalence of dementia and cognitive impairment in hospitals
. Dtsch Arztebl Int
. 2018
;115
(44
):733
–40
. .3.
Vassallo
M
, Poynter
L
, Kwan
J
, Sharma
JC
, Allen
SC
. A prospective observational study of outcomes from rehabilitation of elderly patients with moderate to severe cognitive impairment
. Clin Rehabil
. 2016
;30
(9
):901
–8
. .4.
Tarazona‐Santabalbina
FJ
, Belenguer‐Varea
Á
, Rovira Daudi
E
, Salcedo Mahiques
E
, Cuesta Peredó
D
, Doménech‐Pascual
JR
, et al Severity of cognitive impairment as a prognostic factor for mortality and functional recovery of geriatric patients with hip fracture
. Geriatr Gerontol Int
. 2015
;15
(3
):289
–95
.5.
Hajek
A
, Brettschneider
C
, Brettschneider
C
, van den Bussche
H
, Kaduszkiewicz
H
, Oey
A
, et al Longitudinal analysis of outpatient physician visits in the oldest old: results of the AgeQualiDe prospective cohort study
. J Nutr Health Aging
. 2018
;22
(6
):689
–94
. .6.
Brettschneider
C
, Hajek
A
, Stein
J
, Luck
T
, Mamone
S
, Wiese
B
, et al Informelle Pflege bei Demenz nach Leistungsarten
. Nervenarzt
. 2018
;89
(5
):509
–15
. .7.
Michalowsky
B
, Thyrian
JR
, Eichler
T
, Hertel
J
, Wucherer
D
, Flessa
S
, et al Economic analysis of formal care, informal care, and productivity losses in primary care patients who screened positive for dementia in Germany
. J Alzheimers Dis
. 2016
;50
(1
):47
–59
. 8.
Forbes
D
, Forbes
SC
, Blake
CM
, Thiessen
EJ
, Forbes
S
. Exercise programs for people with dementia
. Cochrane Database Syst Rev
. 2015
;(4
):CD006489
. .9.
Hauer
K
, Ullrich
P
, Dutzi
I
, Beurskens
R
, Kern
S
, Bauer
J
, et al Effects of standardized home training in patients with cognitive impairment following geriatric rehabilitation: a randomized controlled pilot study
. Gerontology
. 2017
;63
(6
):495
–506
. .10.
Davis
JC
, Robertson
MC
, Ashe
MC
, Liu-Ambrose
T
, Khan
KM
, Marra
CA
. Does a home-based strength and balance programme in people aged or = 80 years provide the best value for money to prevent falls? a systematic review of economic evaluations of falls prevention interventions
. Br J Sports Med
. 2010
;44
:80
–9
.11.
Farag
I
, Howard
K
, Hayes
AJ
, Ferreira
ML
, Lord
SR
, Close
JT
, et al Cost-effectiveness of a home-exercise program among older people after hospitalization
. J Am Med Dir Assoc
. 2015
;16
(6
):490
–6
. .12.
Fairhall
N
, Sherrington
C
, Kurrle
SE
, Lord
SR
, Lockwood
K
, Howard
K
, et al Economic evaluation of a multifactorial, interdisciplinary intervention versus usual care to reduce frailty in frail older people
. J Am Med Dir Assoc
. 2015
;16
(1
):41
–8
. .13.
Williams
NH
, Roberts
JL
, Din
NU
, Totton
N
, Charles
JM
, Hawkes
CA
, et al Fracture in the elderly multidisciplinary rehabilitation (FEMuR): a phase II randomised feasibility study of a multidisciplinary rehabilitation package following hip fracture
. BMJ Open
. 2016
;6
(10
):e012422
. .14.
Khan
I
, Petrou
S
, Khan
K
, Mistry
D
, Lall
R
, Sheehan
B
, et al Does structured exercise improve cognitive impairment in people with mild to moderate dementia? a cost-effectiveness analysis from a confirmatory randomised controlled trial: the dementia and physical activity (DAPA) trial
. Pharmacoecon Open
. 2019
;3
(2
):215
–27
. .15.
D’Amico
F
, Rehill
A
, Knapp
M
, Lowery
D
, Cerga-Pashoja
A
, Griffin
M
, et al Cost-effectiveness of exercise as a therapy for behavioural and psychological symptoms of dementia within the EVIDEM-E randomised controlled trial
. Int J Geriatr Psychiatry
. 2016
;31
:656
–65
.16.
Ramsey
SD
, Willke
RJ
, Glick
H
, Reed
SD
, Augustovski
F
, Jonsson
B
, et al Cost-effectiveness analysis alongside clinical trials II-An ISPOR good research practices task force report
. Value Health
. 2015
;18
(2
):161
–72
. .17.
Drummond
MF
, Sculpher
MJ
, Torrance
GW
, O’Brien
BJ
, Stoddart
GL
. Methods for the economic evaluation of health care programmes
. Oxford
: Oxford University Press
; 2005
.18.
Bongartz
M
, Kiss
R
, Ullrich
P
, Eckert
T
, Bauer
J
, Hauer
K
. Development of a home-based training program for post-ward geriatric rehabilitation patients with cognitive impairment: study protocol of a randomized-controlled trail
. BMC Geriatr
. 2017
;17
(1
):214
. .19.
Guralnik
JM
, Simonsick
EM
, Ferrucci
L
, Glynn
RJ
, Berkman
LF
, Blazer
DG
, et al A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission
. J Gerontol
. 1994
;49
(2
):M85
–94
. .20.
EuroQol Group
. EuroQol: a new facility for the measurement of health-related quality of life
. Health Policy
. 1990
;16
(3
):199
–208
.21.
Greiner
W
, Claes
C
, Busschbach
JJ
, von der Schulenburg
JM
. Validating the EQ-5D with time trade off for the German population
. Eur J Health Econ
. 2005
;6
(2
):124
–30
. .22.
Folstein
MF
, Folstein
SE
, McHugh
PR
. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
. J Psychiatr Res
. 1975
;12
(3
):189
–98
. .23.
Seidl
H
, Bowles
D
, Bock
J-O
, Brettschneider
C
, Greiner
W
, König
H-H
, et al FIMA-Fragebogen zur Erhebung von Gesundheitsleistungen im Alter: Entwicklung und Pilotstudie
. Gesundheitswesen
. 2015
;77
:46
–52
.24.
Bock
J-O
, Brettschneider
C
, Seidl
H
, Bowles
D
, Holle
R
, Greiner
W
, et al Ermittlung standardisierter Bewertungssätze aus gesellschaftlicher Perspektive für die gesundheitsökonomische Evaluation
. Gesundheitswesen
. 2015
;77
:53
–61
.25.
© Statistisches Bundesamt: Statistisches Bundesamt Deutschland: GENESIS-Online, © Statistisches Bundesamt (Destatis), 2019. Available from: https://www-genesis.destatis.de/genesis/online/logon?language = de&sequenz = tabelleErgebnis&selectionname = 61111--0001&startjahr = 1991 (accessed 2019 Jun 18)
.26.
Statistisches Bundesamt: Verbraucherpreisindex für Deutschland. Available from: https://www.destatis.de/DE/Themen/Wirtschaft/Preise/Verbraucherpreisindex/Publikationen/Downloads-Verbraucherpreise/verbraucherpreisindex-lange-reihen-pdf-5611103.html (accessed 2020 Jan 28)
.27.
Entgelttabellen Öffentlicher Dienst 2015. Available from: https://oeffentlicher-dienst.info/c/t/rechner/tvoed/bund/a/2015?id = tvoed-bund-2015&matrix = 1 (accessed 2019 Jun 18)
.28.
Manca
A
, Hawkins
N
, Sculpher
MJ
. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility
. Health Econ
. 2005
;14
(5
):487
–96
. .29.
Rubin
DB
. Multiple Imputation for nonresponse in surveys. Wiley series in probability and mathematical statistics applied probability and statistics
. New York, NY
: Wiley
; 1987
.30.
Perera
S
, Mody
SH
, Woodman
RC
, Studenski
SA
. Meaningful change and responsiveness in common physical performance measures in older adults
. J Am Geriatr Soc
. 2006
;54
(5
):743
–9
. .31.
Briggs
AH
, O’Brien
BJ
, Blackhouse
G
. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies
. Annu Rev Public Health
. 2002
;23
:377
–401
. .32.
Brand
J
, van Buuren
S
, Le Cessie
S
, van den Hout
W
. Combining multiple imputation and bootstrap in the analysis of cost-effectiveness trial data
. Stat Med
. 2019
;38
(2
):210
–20
. .33.
Hoch
JS
, Briggs
AH
, Willan
AR
. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis
. Health Econ
. 2002
;11
(5
):415
–30
. .34.
Eckert
T
, Bongartz
M
, Ullrich
P
, Abel
B
, Christian
W
, Kiss
R
, et al Promoting physical activity in geriatric patients with cognitive impairment after discharge from ward-rehabilitation: a feasibility study
. Eur J Ageing
. 2020
;27
:379
.35.
Hickey
A
, Barker
M
, McGee
H
, O’Boyle
C
. Measuring health-related quality of life in older patient populations: a review of current approaches
. Pharmacoeconomics
. 2005
;23
(10
):971
–93
. .36.
O’Hoski
S
, Bean
JF
, Ma
J
, So
HY
, Kuspinar
A
, Richardson
J
, et al Physical function and frailty for predicting adverse outcomes in older primary care patients
. Arch Phys Med Rehabil
. 2020 Apr
;101
(4
):592
–8
.37.
Denkinger
MD
, Lukas
A
, Herbolsheimer
F
, Peter
R
, Nikolaus
T
. Physical activity and other health-related factors predict health care utilisation in older adults: the ActiFE Ulm study
. Z Gerontol Geriatr
. 2012
;45
(4
):290
–7
. .38.
Ullrich
P
, Eckert
T
, Bongartz
M
, Werner
C
, Kiss
R
, Bauer
JM
, et al Life-space mobility in older persons with cognitive impairment after discharge from geriatric rehabilitation
. Arch Gerontol Geriatr
. 2019 Mar–Apr
;81
:192
–200
. .39.
Enders
CK
. Multiple imputation as a flexible tool for missing data handling in clinical research
. Behav Res Ther
. 2017
;98
:4
–18
. .40.
Heider
D
, Matschinger
H
, Müller
H
, Saum
K-U
, Quinzler
R
, Haefeli
WE
, et al Health care costs in the elderly in Germany: an analysis applying Andersen’s behavioral model of health care utilization
. BMC Health Serv Res
. 2014
;14
:71
.41.
Martin
A
, Meads
D
, Griffiths
AW
, Surr
CA
. How should we capture health state utility in dementia? comparisons of DEMQOL-proxy-U and of self- and proxy-completed EQ-5D-5L
. Value Health
. 2019
;22
(12
):1417
–26
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
